management, with absolute contraindication for early post operative cases ie. within 3 weeks. No large randomized trials have been reported in postoperative cases of pulmonary thromboembolism till date. Aim: This retrospective study was aimed to evaluate the use of Tenectaplase in postoperative cases of acute pulmonary thromboembolism. Methods: Ten post operative cases of acute pulmonary thromboembolism, confirmed by CT pulmonary angiography, in which Tenectaplase (Velix) was the drug of choice for thrombolysis were selected (with their high risk consent). Electrocardiography, RV dysfunction by 2D echocardiography and clinical conditions such as tachypnea, hypotension and oxygen saturation were measured and analyzed statistically. Results: Initially all patients were tachypneic of which 50% had hypotension and 9/10 had hypoxia. Thrombolytic treatment with single intravenous bolus of Tenectaplase (30/40 mg) could significantly (p < 0.0001) improve RV function. Improvement in hypotension was observed in 3/5 cases, whereas 1/9 failed to improve hypoxia. Only 1/10 case expired due to intracranial heamorhage immediately after thrombolysis. In one case, Tenectaplase was given intra-arterial but the patient died after few days after IC bleed. Conclusion: Early diagnosis and treatment of pulmonary embolism with potent thrombolytics can be life saving. Though this study was conducted in small sample population for a short duration the result of this study concluded that Tenectaplase can be a potent thrombolytic agent which can be used as drug of choice in postoperative cases of acute pulmonary thromboembolism with high consent. But its potential complication and risk factors should be managed promptly.
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Reappraisal of temporal dispersion of arrhythmias in acute myocardial infarction after thrombolysis in initial 24 hours of presentation
Kamal Kishor, R.K. Gokhroo, Bhanwar L. Ranwa, Sajal Gupta, Devendra Bisht, A. Avinash, Kumari Priti Jawahar Lal Nehru Medical College, Ajmer, India
Background: Temporal dispersion of electrical instability events and hemodynamically significant arrhythmias in myocardial infarction (MI) after thrombolysis is not fully established. Methods: Temporal dispersion of electrical instability events and hemodynamically significant arrhythmias was assessed using 24 hour holter recording in 200 patients of myocardial infarction (MI) presenting within 2 hours. Results: Anterior wall MI had higher incidence of nonsustained ventricular tachycardia and ventricular ectopy with marked decrease in beat to beat (BB) variability, predisposing this group for malignant arrhythmias. Inferior wall MI showed more bradyarrhythmic events and higher BB variability (P value<0.05). Electrical instability after MI predominates in the first 8-10 hours (P value <0.05) and tends to subside thereafter. i n d i a n h e a r t j o u r n a l 6 6 ( 2 0 1 4 ) s 1 es 1 4 3 S122
